Location History:
- Gyeonggi-do, KR (2017)
- Yongin-si, KR (2019)
Company Filing History:
Years Active: 2017-2019
Title: Yi Mi Kim: Innovator in Microsphere Technology
Introduction
Yi Mi Kim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of microsphere technology, holding 2 patents that focus on innovative methods for preparing microspheres. His work has the potential to enhance drug delivery systems and improve the efficiency of various applications.
Latest Patents
Yi Mi Kim's latest patents include a continuous process for preparing microspheres and a method of preparing microspheres using a polymer with sol-gel transition properties. The first patent describes a continuous process that involves injecting two emulsions simultaneously to form microspheres instantaneously. This method addresses the scale variables that have been a major disadvantage in existing preparation methods, improving drug encapsulation efficiency and producing small, uniform particles. The second patent focuses on using a polymer with sol-gel transition properties to create microspheres with reduced porosity and surface roughness. This innovation aims to enhance the encapsulation ratio of bioactive substances, making it a valuable advancement in the field.
Career Highlights
Yi Mi Kim is currently associated with CJ Healthcare Corporation, where he continues to develop and refine his innovative techniques in microsphere preparation. His work is instrumental in advancing the capabilities of drug delivery systems and other applications that rely on microsphere technology.
Collaborations
Some of his notable coworkers include Sun Kyung Lim and Young Joon Park, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Yi Mi Kim's contributions to microsphere technology exemplify the impact of innovative thinking in the field of pharmaceuticals. His patents not only address existing challenges but also pave the way for future advancements in drug delivery systems.